Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
38.89
+1.16 (3.07%)
At close: Sep 11, 2026, 4:00 PM EDT
38.50
-0.39 (-1.00%)
After-hours: Sep 11, 2026, 7:55 PM EDT
Definium Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $66 | Buy | Maintains | $66 | +69.71% | Sep 11, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $75 | Buy | Reiterates | $75 | +92.85% | Sep 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $64 | Buy | Reiterates | $64 | +64.57% | Sep 2, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $72 | Buy | Maintains | $72 | +85.14% | Aug 31, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $60 | Buy | Maintains | $60 | +54.28% | Aug 31, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Initiates $1 → $75 | Buy | Initiates | $1 → $75 | +92.85% | Aug 18, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $75 | Buy | Reiterates | $75 | +92.85% | Aug 17, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $50 → $55 | Buy | Reiterates | $50 → $55 | +41.42% | Aug 14, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.